Home > Healthcare IT > Veterinary Pharmaceutical Drugs Market Share | 2021-27 | Trends, Analysis & Covid-19 Impac
Straits Research

Veterinary Pharmaceutical Drugs Market

Veterinary Pharmaceutical Drugs Market: Information by Disease (Swine Influenza, Osteoarthritis, Newcastle Disease), Drug Types (Swine Drug, Poultry Drug), and Region — Forecast till 2027

Table of Content Download Sample

Market Overview

The global veterinary pharmaceuticals drugs market was worth USD 41,633.76 million during 2020 and is expected to reach USD 64,796.09 million by 2026 at a CAGR of 7.56%.

The Prevalence of Infectious and Chronic Illnesses Propel the Veterinary Pharmaceuticals Drugs Industry

The rising prevalence of infectious and chronic illnesses is propelling the veterinary medication industry. The global Veterinary Pharmaceutical Drugs Market is expected to increase at a higher CAGR by 2030.

Likewise, the world cattle population has grown swiftly over the last few decades. According to the USDA, there were nearly 103 million cattle and 32.1 million beef cows in the U.S. as of July 2020. These numbers are projected to expand significantly in the coming years.

In addition, increased research and development (R&D) and procedural developments, pet adoption rates, rising meat consumption, and mandated immunization are expected to drive the demand for veterinary medications and vaccines for pets.

Market Snapshot

market snapshot
Base Year
: 2021
Study Period
: 2019-2027
: 7.56 %
Fastest Growing Market
: Europe
Largest Market
: North America
Market Size
: USD 64,796.09 million
Get more information on this report Download Sample Report

Market Dynamics

The Rising Demand Vaccines, Medical Feed Supplements, Mergers of Key Players Driving the Growth of the Market:

  • Pharmaceuticals led the veterinary medication market in 2020, with a revenue share of over 57% since the prevalence of bacterial infections, brucellosis, and other food-borne infections is increasing.
  • The market is divided into three product categories: biologics, medicines, and medicated food supplements. Biologics are further subdivided into vaccinations and others. I immunomodulatory, monoclonal antibodies, hormone supplements are examples of others.
  • Pharmaceuticals are further classified as anti-infectives, analgesics, parasiticides, anti-inflammatory drugs, and so forth.
  • Due to the growing consumption of vaccines across livestock and companion animals for disease prevention, the biologics sector is expected to expand the quickest in the veterinary medicine market throughout the forecast period. According to CNN, the United Kingdom Department for Environment, Food, and Rural Affairs confirmed the emergence of H5N1 avian flu at a chicken farm in Suffolk. In December 2019, 27,000 birds were slaughtered humanely as a result of the sickness.
  • The medical feed supplements market is also predicted to rise rapidly throughout the forecast period, owing to their growing use in animal health maintenance.
  • The growing worldwide population increases consumption of meat and dairy products, promoting the expansion of the medical feed additives industry.
  • A considerable number of acquisitions and mergers performed by leading market players to extend their product range of vaccines is predicted to improve the growth potential.

Regional Analysis

Animal Adoption and Product Launches Accelerate Market Growth Dynamics in North America:

The animal medication industry is likely to be driven by the rising adoption of veterinary medication. Essentially, the global veterinary medication sector is unexplored and has low penetration rates, creating a substantial market opportunity. Veterinary medication penetration rates are under 1% in industrialized economies such as the U.S. and around 20% in Western European nations such as the U.K. The veterinary pharmaceuticals drugs industry in the U.S. is predicted to expand from USD 1 billion in 2018 to USD 2 billion in 2022, growing at a higher CAGR due to rising consumer awareness and rising disposable income.

North America dominates the global veterinary medication industry, accounting for more than 37.4% of the market share in 2020. Growth in this region is expected to be driven by increased animal adoption and new and improved products. The consumption of veterinary pharmaceuticals in industrialized nations is expanding due to high animal ownership and rigorous animal healthcare rules. Besides, R&D activities lead to the development of new treatments, increasing the demand further.

European nations are gaining ground due to favorable government rules such as the EU Veterinary Medicines Regulation and increased acceptance of pet insurance in Europe. Due to stringent animal health rules, the veterinary pharmaceuticals drugs industry in Europe will continue to rise.

Increasing the use of modern veterinary medications in Asia-Pacific, particularly in developing nations such as India and China, will drive market expansion over the forecast period. Animal health knowledge is growing in Asia-Pacific due to government initiatives, increased use of animals in agriculture, and rising disposable incomes, which leads to higher veterinary medicine spending.

The rising occurrence of zoonotic illnesses and advantageous reimbursement plans are primary contributors to the dominion. According to the Centers for Disease Control and Prevention, zoonotic infections are widespread in the U.S. and across the world. It is believed that 6 out of 10 identified infectious diseases can be transferred by animals, while animals cause 3 out of 4 emerging infections in humans. Further, the rising acceptance of pet health insurance in the U.S. is likely to boost the growth.

The market for veterinary medication in Asia-Pacific is predicted to rise rapidly over the projected period. Factors such as the increased popularity of companion animals and animal health hazards have fueled market expansion in the area. Further, rising expenditure on animal health and veterinary services and an increase in cattle population boost the veterinary medication industry.

Veterinary Pharmaceutical Drugs Market Regional Analysis
Regional Growth Insights Download Free Sample

Top Key Players of Veterinary Pharmaceutical Drugs Market

In order to stay competitive, market leaders engage in strategic alliances, geographical growth, and new product launches. Established companies and giant corporations acquire other market competitors to obtain a competitive advantage.

Ceva inked a deal with ProBioGen Ag in October 2019 to manufacture vectorized chicken vaccinations utilizing ProBioGen's patented AGE1.CR technologies. It aided both firms in solidifying their long-term collaboration and expertise in creating new vaccines.In 2020, the veterinary hospitals and clinics sector led the Veterinary Pharmaceutical Drugs Market, with a revenue share of more than 72.0 %. The latest diagnostic imaging, innovative therapeutics, nuclear and regenerative medicines, laser diagnostics, and specialist operations offered in veterinary hospitals and clinics are all contributing to the increase.

The release of Poulvac Procerta HVT-ND, a vectored recombinant vaccine for protection against Newcastle and Marek's disease viruses, by Zoetis, a prominent animal health business, in January 2020, greatly increased the company's poultry vaccine range.

Merck bought IdentiGEN, a firm specializing in DNA-based animal traceability solutions for aquaculture and cattle, in August 2020.

Elanco bought Bayer's Animal Health Business in August 2020 to grow Elanco's scale and capabilities, establishing the firm for the long run as a pioneer in the appealing, long-lasting veterinary pharmaceutical  drugs industry. Among the leading businesses in the veterinary medicine market are:

  1. Elanco
  2. Merck Animal Health
  3. Vetoquinol S.A.
  4. Boehringer Ingelheim GmbH
  5. Ceva Sante Animale
  6. Zoetis
  7. Kindred Biosciences, Inc.
  8. Nutreco N.V.
  9. Virbac
  10. Biogenesis Bago
  11. Neogen Corporation
  12. Philbro Animal Health
  13. Hester Biosciences
  14. Indian Immunologicals Ltd.

Report Scope

Report Metric Details
CAGR 7.56%
Forecast Period 2023-2031
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
Segments Covered
  1. By Animal Type:
    1. Production
    2. Companio
  2. By Product:
    1. Biologics
    2. Pharmaceuticals
    3. Medicated Feed Additives
Geographies Covered
  • North America
  • Europe
  • APAC
  • Middle East and Africa

Veterinary Pharmaceutical Drugs Market Segmentation

By Animal Type:

  • Production
  • Companio

By Product:

  • Biologics
  • Pharmaceuticals
  • Medicated Feed Additives

By Regions:

  • Americas
  • Europe
  • Asia-Pacific
  • The Middle East and Africa

Frequently Asked Questions (FAQs)

What is the growth rate for the Veterinary Pharmaceutical Drugs Market?
Veterinary Pharmaceutical Drugs Market size will grow at approx. CAGR of 7.56% during the forecast period.
Some of the top industry players in Veterinary Pharmaceutical Drugs Market are, Elanco, Merck Animal Health, Vetoquinol S.A., Boehringer Ingelheim GmbH, Ceva Sante Animale, Zoetis, Kindred Biosciences, Inc., Nutreco N.V., Virbac, Biogenesis Bago, Neogen Corporation, Philbro Animal Health, Hester Biosciences, Indian Immunologicals Ltd., etc.
North America has been dominating the Veterinary Pharmaceutical Drugs Market, accounting for the largest share of the market.
The Veterinary Pharmaceutical Drugs Market has seen the most substantial growth rate in Europe.
The global Veterinary Pharmaceutical Drugs Market report is segmented as follows: By Animal Type, By Product
Price Starts From
USD 995

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report
Want to learn more about recent trends and data ?
They Already Trust Us :
Nippon Becton Dickinson
Argon Medical Devices
Johnson & Johnson
Need Assistance?
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)

Report Benefits

  • Develop business strategies by understanding the trends shaping and driving the Market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track sales in the global and country-specific Market.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Report Snapshot
Looking For Custom Report ?
Check Our License Options :

As featured on :

Trusted by Fortune 500
Over 30000+ subscribers